Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Cash from Financing Activities: 2009-2024

Historic Cash from Financing Activities for Nutex Health (NUTX) over the last 15 years, with FY2024 value amounting to $1.1 million.

  • Nutex Health's Cash from Financing Activities fell 700142.52% to -$29.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$59.0 million, marking a year-over-year decrease of 70401.52%. This contributed to the annual value of $1.1 million for FY2024, which is 14805.63% up from last year.
  • According to the latest figures from FY2024, Nutex Health's Cash from Financing Activities is $1.1 million, which was up 14805.63% from -$2.3 million recorded in FY2023.
  • In the past 5 years, Nutex Health's Cash from Financing Activities ranged from a high of $1.1 million in FY2024 and a low of -$125.9 million during FY2021
  • Over the past 5 years, Nutex Health's median Cash from Financing Activities value was -$8.0 million (recorded in 2020), while the average stood at -$36.6 million.
  • In the last 5 years, Nutex Health's Cash from Financing Activities crashed by 147849.74% in 2021 and then surged by 14805.63% in 2024.
  • Nutex Health's Cash from Financing Activities (Annual) stood at -$8.0 million in 2020, then plummeted by 1478.5% to -$125.9 million in 2021, then soared by 61.75% to -$48.1 million in 2022, then surged by 95.28% to -$2.3 million in 2023, then surged by 148.06% to $1.1 million in 2024.
  • Its Cash from Financing Activities stands at $1.1 million for FY2024, versus -$2.3 million for FY2023 and -$48.1 million for FY2022.